Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class ASSE: 600196

Announcement on New Drug Indication Obtaining Registration Approval for a Holding Subsidiary

· Issued by Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on New Drug Indication Obtaining Registration Approval for a Holding Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment